Huron Capital Launches Fifteenth ExecFactor® Platform In Partnership With Industry Executive
DETROIT, MI, September 19, 2017 – Huron Capital has co-founded Brudner Polymer Corporation (“Brudner”) with David Brunori to build a platform company in the adhesives and sealants industry. Through Brudner, Huron Capital plans to invest in technologically-advanced adhesive and sealant companies serving a variety of geographies and end markets.
“We are excited to partner with David Brunori, an experienced operator,” said Mike Beauregard, Senior Partner at Huron Capital. “This is Huron Capital’s fifteenth ExecFactor® platform and the fourth in the specialty chemicals space after Quest Specialty Chemicals, Optimum Plastics and Valentus Specialty Chemicals. We think our executive-led buy-and-build investment model is well suited for this industry.”
“It is great to be partnered again with Huron Capital,” added Brunori. “I’ve known the Huron Capital team for over 10 years, having run the largest division of Quest Specialty Chemicals, and I have seen first-hand the support they provide to their ExecFactor® CEOs. I am excited to lead this new initiative as we strive to build a significant platform in the adhesives and sealants sector.”
The Brudner initiative is targeting companies with the following characteristics:
- Focus on fragmented end markets including (but not limited to) construction/infrastructure, transportation, and OEM/assembly;
- Proven ability to meet customer needs with unique adhesive and/or sealant solutions and exceptional customer service;
- Annual revenues of least $20 million; and
- Strong recurring revenue base with high customer retention.
About Huron Capital
Based in Detroit, Huron Capital is an operationally-focused private equity firm with a long history of growing lower middle-market companies through our proprietary ExecFactor® buy-and-build investment model. We prefer complex situations where we can help companies reach their full potential by combining our operational approach, substantial capital base, and transaction experience with seasoned operating executives. Founded in 1999, Huron Capital has raised over $1.7 billion in capital through six committed private equity funds and invested in over 140 companies, and our portfolio companies have employed over 11,000 people throughout North America. The Huron Capital buy-and-build investment model includes equity recapitalizations, family succession transactions, market-entry strategies, corporate carve-outs, and management buyouts of companies having revenues up to $200 million. Huron Capital targets both control and non-control equity stakes in fundamentally-sound companies that can benefit from the firm’s operational approach to creating value. Huron Capital’s sector focus includes business services, consumer products & services and specialty industrials. For more information, please visit www.huroncapital.com.
About David Brunori
David is a veteran executive with more than 30 years in the specialty chemical industry. Most recently, he was the Business Director (Americas) for Valspar Automotive, where he focused on P&L management and the execution of business strategy across multiple functions; primary areas of emphasis included commercial activities and competitive strategies. From 2006-2015, David was President of Quest Automotive Products, which provided a variety of advanced technology paint and coatings systems to the automotive refinish market. Earlier in his career, David worked as a formulating chemist at Lilly Industries and PPG Industries.
Certain information herein may contain forward-looking statements which are provided to assist the reader in understanding the beliefs and opinions with respect to future opportunities as perceived by Huron Capital and others quoted herein. These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance in future periods to differ materially from any projections or results expressed or implied by such forward-looking statements. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The issuer of these statements undertakes no obligation to update forward-looking statements if circumstances or estimates or opinions should change except as may be required by applicable securities laws.